Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
pheniramine (Amros Pharmaceuticals)
- Development stage
- Unknown
- Lead developer
- Amros Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Intravenous, Intramuscular
01
Overview
Amrovil is a brand of pheniramine maleate, a first-generation alkylamine antihistamine manufactured by Amros Pharmaceuticals. It functions as a competitive antagonist at the histamine H1 receptor, effectively blocking the physiological effects of histamine. It is primarily indicated for the treatment of various allergic conditions, including allergic rhinitis, urticaria, and hay fever. Due to its ability to cross the blood-brain barrier, it also possesses significant sedative properties and is sometimes used for the management of motion sickness and as a mild sedative. In the context of Amros Pharmaceuticals, it is provided as an injectable formulation for rapid relief of acute allergic symptoms.
- Brand names
- AmrovilAvil
- Other names
- pheniramine maleate
02
Targets
HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)
Beyond the preview
Go deeper on pheniramine (Amros Pharmaceuticals).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on pheniramine (Amros Pharmaceuticals).